首页> 外文OA文献 >1084P Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial

【2h】

1084P Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial

机译：1084p Cosibelimab，一种抗PD-L1抗体，转移皮肤鳞状细胞癌（MCSCC）：I临床试验中的初步安全性和疗效结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P. Clingan; D. Brungs; R. Ladwa; A.M. Mant; M. McGrath; A. Tazbirkova; P. Koralewski; I. Lugowska; C. Charoentum; A. Dechaphunkul; V. Sriuranpong; J. Oliviero; D.L. Harris;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 399?Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial [J] . Dean Harris, Daniel Brungs, Rahul Ladwah, Journal for ImmunoTherapy of Cancer . 2020,第Suppla3期

机译：399？Cosibelimab，一种抗PD-L1抗体：全球性，多层阶段1临床试验的初步安全性和疗效结果
2. Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single‐arm phase 2 clinical trial [J] . Gold Kathryn A., Kies Merrill S., William William N., Cancer: A Journal of the American Cancer Society . 2018,第10期

机译：Erlotinib治疗复发或转移皮肤鳞状细胞癌：单臂2阶段临床试验
3. Safety and efficacy of programmed cell death‐1 antibody SHR‐1210 combined with concurrent chemoradiotherapy to treat locally advanced esophageal squamous cell carcinoma: a study protocol for an exploratory single‐arm phase Ib trial [J] . Xiaoying Wei, Zhoubo Guo, Wencheng Zhang, Precision Radiation Oncology . 2020,第4期

机译：编程细胞死亡-1抗体SHR-1210的安全性和有效性联合同时进行化学疗法，治疗局部晚期食管鳞状细胞癌：探索式单臂相位IB试验的研究方案
4. PHASE I/II TRIAL OF DUAL AGENT POLYAMINE DEPLETION THERAPY FOR FELINE ORAL SQUAMOUS CELL CARCINOMA [C] . Katherine A Skorupski, Thomas OBrien, Mark Burns, Annual conference of the Veterinary Cancer Society . 2008

机译：双药剂多胺耗竭治疗猫鳞状鳞状细胞癌的I / II试验
5. Cutaneous clear cell squamous cell carcinoma in situ: Clinical, morphological and immunohistochemical characterization. [D] . Al-Arashi, Munir Yahya Hussein. 2005

机译：皮肤透明细胞鳞状细胞癌原位：临床，形态学和免疫组化特征。
6. Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single Arm Phase II Clinical Trial [O] . Kathryn A. Gold, Merrill S. Kies, William N. William Jr, -1

机译：厄洛替尼治疗复发或转移性皮肤鳞状细胞癌：单臂II期临床试验
7. Safety and Efficacy of PD-1 Antibody SHR-1210 Combined with Concurrent Chemoradiotherapy to Treat Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase Ib Clinical Trial [O] . Q. Pang, W. Zhang, J. Zhao, 2020

机译：PD-1抗体SHR-1210的安全性和功效联合同时的化疗治疗局部晚期食管鳞状细胞癌：IA相临床试验

1084P Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial

著录项

引文网络

相似文献

相关主题

期刊订阅